Primary Recipient

INTERTHYR CORPORATION

Amount

$2,652,865.00

Award Date

9/21/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

DESCRIPTION (provided by applicant): Interthyr Corporation (IC) is requesting an Advanced Technology Phase II STTR award to develop a novel agent with a new therapeutic paradigm: Inhibition of Toll-like receptor (TLR) expression and signaling in non-immun

Recipients Connected to Award

Recipient	Role	Amount
INTERTHYR CORPORATION	Primary recipient	$1,766,171.00
OHIO UNIVERSITY	Sub-recipient	$886,694.00

Vendors Connected to Award

Vendor	Role	Amount
Ricerca Biosciences, LLC	Primary vendor	$207,422.50
Applied Biosystems	Primary vendor	$39,902.46
Molecular Devices	Primary vendor	$31,844.32
Full & Hupp CPAs, Inc.	Primary vendor	$33,996.00
Interthyr Corporation	Primary vendor	$237,162.25
Jackson Biotechnology Advisors, LLC	Primary vendor	$27,000.00